About Vitrolife
Vitrolife is a company based in Goteborg (Sweden) founded in 1994. Vitrolife has completed 5 acquisitions, including Cryo Innovation, FertiliTech and Igenomix.
- Headquarter Goteborg, Sweden
- SectorsHealthcare
- Website vitrolife.com
- Social LinkedIn X
- Legal Name Vitrolife Ab
- Annual Revenue$373.52 M (USD)-4.68as on Dec 31, 2025
- Net Profit-$543.99 M (USD)-1077as on Dec 31, 2025
- EBITDA$112.92 M (USD)-15.75as on Dec 31, 2025
- Investments & AcquisitionsCryo Innovation
& 4 more
People of Vitrolife
57 people are tracked at Vitrolife (10 in leadership, 6 in board & advisors, 41 in team).
| Name | Role | Group |
|---|---|---|
Thomas Axelsson | CEO | Leadership |
Guillermo Ferrando | VP, Strategy & Corporate Development | Leadership |
Patrik Tolf | CFO | Leadership |
Guillermo Gutiérrez Martín | Head Of Group Internal Control & Enterprise Risk Management | Leadership |
Rasmus Theilmann | VP R&d, Vitrolife Technologies | Leadership |
Andrea S. G. | Director Of Human Resources, North America | Leadership |
Chris Liu | Marketing Director, Market Region Asia | Leadership |
Kristian Ehlers | Director Software Solutions, R&d | Leadership |
Andrea Sykes | National Account Director, Technologies | Leadership |
Cristina Iranzo Ocete | Business Development And Distributors Director Israel And Africa | Leadership |
Henrik Blomquist | Board member | Board & advisors |
Lars Holmqvist | Director | Board & advisors |
Pia Marions | Director | Board & advisors |
Vesa Koskinen | Independent Director | Board & advisors |
Karen Lykke Sørensen | Independent Director | Board & advisors |
Jón Sigurdsson | Chairman | Board & advisors |
Jonathan Grinderslev Krukow | Seniorsoftwareudvikler | Team |
Claus Bisgaard | SVP, Technologies | Team |
Jenny Dejve Abrahamsson | Finance Transformation | Team |
Souichi Ogata | APAC Scientific Leader | Team |
37 more people are available in the full profile.
Complete people profiles for Vitrolife
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Vitrolife
Vitrolife is a publicly listed company on the OMXSTO with ticker symbol VITR in Sweden, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date19 Jun 2001
- Listed onOMXSTO: VITR
- Listed entityVitrolife AB
- Exchange sectorHealth technology
- ISINSE0011205202
- Share price95.60 SEK (+2.69% on the day) · 2026-10-09
- Market capitalisation12,948,751,093.00 SEK
- Price to earnings41.8
- EPS (diluted, trailing year)-36.79 SEK
- Dividend yield1.15%
- Volume (last session)94,749
Financials of Vitrolife
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 3.44B SEK | -5.01B SEK | 1.04B SEK |
| 2024 | 3.61B SEK | 513.0M SEK | 1.24B SEK |
| 2023 | 3.51B SEK | -3.85B SEK | 1.16B SEK |
| 2022 | 3.23B SEK | 394.0M SEK | 1.04B SEK |
| 2021 | 1.68B SEK | 341.0M SEK | 637.8M SEK |
Detailed financial statements for Vitrolife
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vitrolife
Vitrolife has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include Cryo Innovation, FertiliTech and Igenomix.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Cloud-based practice management software for fertility clinics | efertility.eu | Houten, Netherlands | 2007 | May 2024 | $10.25M | |
Reproductive genetic testing services are provided by the medical laboratory. | igenomix.com | Paterna, Spain | 2009 | Jul 2021 | •••• | |
R&D company focused on manufacturing IVF media & devices for multiple therapeutic areas | octax.de | Germany | 2007 | Jun 2016 | •••• | |
Embryo selection in IVF clinics is enhanced by time-lapse technology. | fertilitech.com | Aarhus, Denmark | 2003 | Nov 2014 | •••• | |
Assisted reproduction technologies are developed for humans and animals. | cryo-innovation.com | Mission, United States | 2004 | Jun 2012 | $6.23M |
Complete acquisition details for Vitrolife
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Vitrolife
7 dated milestones of Vitrolife across 30 years, from founding to its latest funding, stage changes and deals.
- Founded Vitrolife is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Cryo Innovation.
- Acquisition Acquires FertiliTech.
- Acquisition Acquires Octax Microscience.
- Acquisition Acquires Igenomix.
- Acquisition Acquires eFertility.
Web traffic of Vitrolife
The website of Vitrolife (vitrolife.com) receives about 25.7K visits a month.
- Monthly visits25.7K
▲ 14.2% vs previous month
Websites whose visitors overlap most with Vitrolife. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| irvinesci.com | 100% | 6.6K | #3,329,806 | View details | |
| zen-bio.com | 100% | 10.8K | #2,170,365 | View details | |
| invitria.com | 83% | – | #3,790,077 | View details | |
| appliedgenetics.com | 82% | 1.2K | #13,396,451 | View details | |
| caissonlabs.com | 80% | 5.2K | #3,842,345 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 10 similar websites and full traffic analytics for Vitrolife
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 10 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Vitrolife
Complete news archive for Vitrolife
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Vitrolife
10 companies that operate in the same segment as Vitrolife (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Vitrolife
Vitrolife was founded in 1994.
Vitrolife is headquartered in Goteborg, Sweden. It is registered at Goteborg, Vastra Gotaland, Sweden.
Thomas Axelsson is the current CEO of Vitrolife.
Annual revenue of Vitrolife is $373.52M as on Dec 31, 2025.
Vitrolife was founded in 1994 in Gothenburg, Sweden, and operates in the reproductive medicine sector. A range of products for in-vitro fertilization clinics is manufactured and supplied, including labware, media, needles, pipettes, time-lapse systems, laser and imaging systems, genomics kits, and cryopreservation equipment. Technical and clinical support is provided, along with educational resources such as webinars and online training. Operations focus on enhancing efficiency in IVF procedures.
Yes, Vitrolife is publicly traded on OMXSTO under the ticker symbol VITR.
Vitrolife has made 5 acquisitions, including Cryo Innovation, FertiliTech, and Igenomix.